Alvimopan for the management of postoperative ileus after bowel resection: Characterization of clinical benefit by pooled responder analysis

37Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: A pooled post hoc responder analysis was performed to assess the clinical benefit of alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist, for the management of postoperative ileus after bowel resection. Methods: Adult patients who underwent laparotomy for bowel resection scheduled for opioid-based intravenous patient-controlled analgesia received oral alvimopan or placebo preoperatively and twice daily postoperatively until hospital discharge or for 7 postoperative days. The proportion of responders and numbers needed to treat (NNT) were examined on postoperative days (POD) 3-8 for GI-2 recovery (first bowel movement, toleration of solid food) and hospital discharge order (DCO) written. Results: Alvimopan significantly increased the proportion of patients with GI-2 recovery and DCO written by each POD (P < 0.001 for all). More patients who received alvimopan achieved GI-2 recovery on or before POD 5 (alvimopan, 80%; placebo, 66%) and DCO written before POD 7 (alvimopan, 87%; placebo, 72%), with corresponding NNTs equal to 7. Conclusions: On each POD analyzed, alvimopan significantly increased the proportion of patients who achieved GI-2 recovery and DCO written versus placebo and was associated with relatively low NNTs. The results of these analyses provide additional characterization and support for the overall clinical benefit of alvimopan in patients undergoing bowel resection. © Société Internationale de Chirurgie 2010.

References Powered by Scopus

'Fast track' postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery

333Citations
N/AReaders
Get full text

Review of postoperative ileus

310Citations
N/AReaders
Get full text

A Survey of Clinical Trials of Antibiotic Prophylaxis in Colon Surgery: Evidence against Further Use of No-Treatment Controls

295Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Clinical Practice Guidelines for Enhanced Recovery after Colon and Rectal Surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons

318Citations
N/AReaders
Get full text

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: Current concepts and future perspectives

157Citations
N/AReaders
Get full text

Identification of clinical outcome measures for recovery of gastrointestinal motility in postoperative ileus

136Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ludwig, K., Viscusi, E. R., Wolff, B. G., Delaney, C. P., Senagore, A., & Techner, L. (2010). Alvimopan for the management of postoperative ileus after bowel resection: Characterization of clinical benefit by pooled responder analysis. World Journal of Surgery, 34(9), 2185–2190. https://doi.org/10.1007/s00268-010-0635-9

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 17

65%

Researcher 6

23%

Professor / Associate Prof. 3

12%

Readers' Discipline

Tooltip

Medicine and Dentistry 24

75%

Nursing and Health Professions 4

13%

Pharmacology, Toxicology and Pharmaceut... 2

6%

Agricultural and Biological Sciences 2

6%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free